Participation of Monocyte Subpopulations in Progression of Experimental Endotoxemia (EE) and Systemic Inflammation

J Immunol Res. 2021 Feb 12;2021:1762584. doi: 10.1155/2021/1762584. eCollection 2021.

Abstract

Systemic inflammation plays a crucial role in formation of various pathological conditions, including sepsis, burns, and traumas. The main effector cells participating in progression of systemic inflammation response and sepsis are monocytes, which regulate both innate and acquired immunity via phagocytosis, synthesis of cytokines and chemokines, antigen presentation, and lymphocyte activation. Thus, the monocytes are considered as a link between innate and acquired immunity. The monocyte subpopulations taken into consideration in the study essentially determine the progression of systemic inflammation and could serve as targets for therapeutic intervention. The complexity of the analysis of pathophysiology of systemic inflammation lies in its high variability conditioned by individual peculiarities of the patients and inflammation progression specifications. To overcome these limitation, model of experimental endotoxemia (EE) is used. The results of EE, in turn, cannot be directly extrapolated on patients with the systemic inflammatory response. This review is dedicated to discussing the role of monocyte subpopulations in progression of systemic inflammation/sepsis and EE.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Plasticity
  • Chemokines / metabolism
  • Cytokines / metabolism
  • Disease Susceptibility*
  • Endotoxemia / etiology*
  • Endotoxemia / metabolism
  • Endotoxemia / pathology
  • Humans
  • Inflammation / etiology*
  • Inflammation / metabolism
  • Inflammation / pathology
  • Monocytes / immunology*
  • Monocytes / metabolism*
  • Sepsis / etiology

Substances

  • Chemokines
  • Cytokines